Furthermore, a non-peptide MasR agonist was found to improve cardiac remodeling and function in rat models of post-MI CHF and chronic beta-adrenoreceptor stimulation-induced cardiac remodeling [26,27]. Here, MAS1L is linked to congestive heart failure.